O	O	O	0	14	Identification	Identification	B-NP	NN	O	0	ROOT	O
O	O	O	15	17	of	of	B-PP	IN	O	1	NMOD	O
O	O	O	18	20	an	an	B-NP	DT	O	2	PMOD	O
T6	B-Entity	B-Entity	21	30	ionomycin	ionomycin	I-NP	NN	O	3	NMOD	O
T6	I-Entity	I-Entity	30	31	/	/	B-VP	SYM	O	4	NMOD	O
T6	I-Entity	I-Entity	31	42	cyclosporin	cyclosporin	B-NP	NN	O	7	NMOD	O
T6	I-Entity	I-Entity	43	44	A	A	I-NP	NN	O	10	NMOD	O
T6	I-Entity	I-Entity	44	45	-	-	B-NP	HYPH	O	10	NMOD	O
T6	I-Entity	I-Entity	45	55	responsive	responsive	I-NP	JJ	B-DNA	10	NMOD	B-DNA
T6	I-Entity	I-Entity	56	63	element	element	I-NP	NN	I-DNA	5	PMOD	I-DNA
O	O	O	64	70	within	within	B-PP	IN	O	10	NMOD	O
O	O	O	71	74	the	the	B-NP	DT	O	18	NMOD	O
O	O	O	75	80	human	human	I-NP	JJ	B-DNA	18	NMOD	B-DNA
T1	B-Protein	B-Protein	81	82	T	T	I-NP	NN	I-DNA	18	NMOD	I-DNA
T1	I-Protein	I-Protein	83	87	cell	cell	I-NP	NN	I-DNA	18	NMOD	I-DNA
T1	I-Protein	I-Protein	88	96	receptor	receptor	I-NP	NN	I-DNA	18	NMOD	I-DNA
T1	I-Protein	I-Protein	97	102	gamma	gamma	I-NP	NN	I-DNA	18	NMOD	I-DNA
T7	B-Entity	B-Entity	103	111	enhancer	enhancer	I-NP	NN	I-DNA	11	PMOD	I-DNA
O	O	O	111	112	.	.	O	.	O	1	P	O

O	O	O	114	124	Activation	Activation	B-NP	NN	O	9	SUB	O
O	O	O	125	132	through	through	B-PP	IN	O	1	NMOD	O
O	O	O	133	136	the	the	B-NP	DT	O	8	NMOD	O
O	O	O	137	140	Ca2	Ca2	I-NP	NN	B-protein	8	NMOD	B-protein
O	O	O	140	141	+	+	O	SYM	O	8	NMOD	O
O	O	O	141	142	/	/	O	SYM	O	8	NMOD	O
T8	B-Entity	B-Entity	142	153	calcineurin	calcineurin	B-NP	NN	B-protein	8	NMOD	B-protein
O	O	O	154	161	pathway	pathway	I-NP	NN	O	2	PMOD	O
O	O	O	162	164	is	be	B-VP	VBZ	O	0	ROOT	O
O	O	O	165	174	essential	essential	B-ADJP	JJ	O	9	PRD	O
O	O	O	175	177	to	to	B-PP	TO	O	10	AMOD	O
O	O	O	178	181	the	the	B-NP	DT	O	13	NMOD	O
O	O	O	182	195	transcription	transcription	I-NP	NN	O	11	PMOD	O
O	O	O	196	198	of	of	B-PP	IN	O	13	NMOD	O
O	O	O	199	203	many	many	B-NP	JJ	O	17	NMOD	O
T9	B-Entity	B-Entity	204	212	cytokine	cytokine	I-NP	NN	B-DNA	17	NMOD	B-DNA
T9	I-Entity	I-Entity	213	218	genes	gene	I-NP	NNS	I-DNA	14	PMOD	I-DNA
O	O	O	218	219	.	.	O	.	O	9	P	O

O	O	O	220	223	The	The	B-NP	DT	O	3	NMOD	O
T10	B-Entity	B-Entity	224	233	conserved	conserve	I-NP	VBN	B-DNA	3	NMOD	B-DNA
T10	I-Entity	I-Entity	234	237	cis	cis	I-NP	NN	I-DNA	12	NMOD	I-DNA
T10	I-Entity	I-Entity	237	238	-	-	O	HYPH	I-DNA	3	P	I-DNA
T10	I-Entity	I-Entity	238	244	acting	act	B-VP	VBG	I-DNA	6	NMOD	I-DNA
T10	I-Entity	I-Entity	245	253	sequence	sequence	B-NP	NN	I-DNA	3	NMOD	I-DNA
O	O	O	253	254	,	,	O	,	O	12	P	O
T11	B-Entity	B-Entity	255	261	GGAAAA	GGAAAA	B-NP	NN	O	12	NMOD	O
O	O	O	261	262	,	,	O	,	O	12	P	O
O	O	O	263	266	and	and	O	CC	O	12	NMOD	O
O	O	O	267	280	transcription	transcription	B-NP	NN	B-protein	12	NMOD	B-protein
O	O	O	281	288	factors	factor	I-NP	NNS	I-protein	17	SUB	I-protein
O	O	O	289	296	binding	bind	B-VP	VBG	O	12	NMOD	O
O	O	O	297	299	to	to	B-PP	TO	O	13	VMOD	O
O	O	O	300	304	this	this	B-NP	DT	O	16	NMOD	O
O	O	O	305	313	sequence	sequence	I-NP	NN	O	14	PMOD	O
O	O	O	314	317	are	be	B-VP	VBP	O	0	ROOT	O
O	O	O	318	326	involved	involve	I-VP	VBN	O	17	VC	O
O	O	O	327	329	in	in	B-PP	IN	O	18	VMOD	O
O	O	O	330	333	the	the	B-NP	DT	O	21	NMOD	O
O	O	O	334	342	response	response	I-NP	NN	O	19	PMOD	O
O	O	O	343	345	to	to	B-PP	TO	O	21	NMOD	O
O	O	O	346	355	increased	increase	B-NP	VBN	O	27	NMOD	O
O	O	O	356	369	intracellular	intracellular	I-NP	JJ	B-protein	25	NMOD	B-protein
O	O	O	370	373	Ca2	Ca2	I-NP	NN	I-protein	27	NMOD	I-protein
O	O	O	373	374	+	+	B-VP	SYM	O	27	NMOD	O
O	O	O	375	389	concentrations	concentration	B-NP	NNS	O	22	PMOD	O
O	O	O	389	390	.	.	O	.	O	17	P	O

O	O	O	391	395	Here	Here	B-ADVP	RB	O	3	VMOD	O
O	O	O	396	398	we	we	B-NP	PRP	O	3	SUB	O
O	O	O	399	405	report	report	B-VP	VBP	O	0	ROOT	O
O	O	O	406	409	the	the	B-NP	DT	O	7	NMOD	O
O	O	O	410	424	identification	identification	I-NP	NN	O	7	NMOD	O
O	O	O	425	428	and	and	I-NP	CC	O	7	NMOD	O
O	O	O	429	439	importance	importance	I-NP	NN	O	28	NMOD	O
O	O	O	440	442	of	of	B-PP	IN	O	7	NMOD	O
O	O	O	443	446	the	the	B-NP	DT	O	11	NMOD	O
O	O	O	447	451	same	same	I-NP	JJ	O	11	NMOD	O
O	O	O	452	460	sequence	sequence	I-NP	NN	O	8	PMOD	O
O	O	O	461	463	in	in	B-PP	IN	O	11	NMOD	O
O	O	O	464	465	a	a	B-NP	DT	O	17	NMOD	O
T12	B-Entity	B-Entity	466	469	non	non	I-NP	AFX	O	17	NMOD	O
T12	I-Entity	I-Entity	469	470	-	-	I-NP	HYPH	B-DNA	17	NMOD	B-DNA
T12	I-Entity	I-Entity	470	478	cytokine	cytokine	I-NP	NN	I-DNA	17	NMOD	I-DNA
T12	I-Entity	I-Entity	479	483	gene	gene	I-NP	NN	I-DNA	12	PMOD	I-DNA
O	O	O	483	484	,	,	O	,	O	28	P	O
O	O	O	485	488	the	the	B-NP	DT	O	28	NMOD	O
O	O	O	489	494	human	human	I-NP	JJ	B-DNA	28	NMOD	B-DNA
T2	B-Protein	B-Protein	495	496	T	T	I-NP	NN	I-DNA	28	NMOD	I-DNA
T2	I-Protein	I-Protein	497	501	cell	cell	I-NP	NN	I-DNA	28	NMOD	I-DNA
T2	I-Protein	I-Protein	502	510	receptor	receptor	I-NP	NN	I-DNA	28	NMOD	I-DNA
T2	I-Protein	I-Protein	511	516	gamma	gamma	I-NP	NN	I-DNA	28	NMOD	I-DNA
O	O	O	517	518	(	(	O	(	I-DNA	28	NMOD	I-DNA
T3	B-Protein	B-Protein	518	522	TCRG	TCRG	B-NP	NN	I-DNA	28	NMOD	I-DNA
O	O	O	522	523	)	)	O	)	I-DNA	28	NMOD	I-DNA
T13	B-Entity	B-Entity	524	532	enhancer	enhancer	B-NP	NN	I-DNA	3	OBJ	I-DNA
O	O	O	532	533	.	.	O	.	O	3	P	O

O	O	O	534	541	Results	Result	B-NP	NNS	O	13	SUB	O
O	O	O	542	546	from	from	B-PP	IN	O	1	NMOD	O
O	O	O	547	551	site	site	B-NP	NN	O	6	NMOD	O
O	O	O	551	552	-	-	B-NP	HYPH	O	6	NMOD	O
O	O	O	552	560	directed	direct	I-NP	VBN	O	6	NMOD	O
O	O	O	561	570	mutations	mutation	I-NP	NNS	O	11	NMOD	O
O	O	O	571	574	and	and	O	CC	O	11	NMOD	O
O	O	O	575	590	electrophoretic	electrophoretic	B-NP	JJ	O	11	NMOD	O
O	O	O	591	599	mobility	mobility	I-NP	NN	O	11	NMOD	O
O	O	O	600	605	shift	shift	I-NP	NN	O	11	NMOD	O
O	O	O	606	612	assays	assay	I-NP	NNS	O	2	PMOD	O
O	O	O	613	621	strongly	strongly	B-VP	RB	O	13	VMOD	O
O	O	O	622	629	suggest	suggest	I-VP	VBP	O	0	ROOT	O
O	O	O	630	634	that	that	B-SBAR	IN	O	13	VMOD	O
O	O	O	635	639	this	this	B-NP	DT	O	16	NMOD	O
O	O	O	640	648	sequence	sequence	I-NP	NN	O	17	SUB	O
O	O	O	649	657	mediates	mediate	B-VP	VBZ	O	14	SBAR	O
O	O	O	658	661	the	the	B-NP	DT	O	19	NMOD	O
O	O	O	662	671	ionomycin	ionomycin	I-NP	NN	O	17	OBJ	O
O	O	O	671	672	-	-	B-VP	HYPH	O	19	NMOD	O
O	O	O	672	679	induced	induce	B-NP	VBN	O	22	NMOD	O
O	O	O	680	690	activation	activation	I-NP	NN	O	20	OBJ	O
O	O	O	691	693	of	of	B-PP	IN	O	22	NMOD	O
O	O	O	694	697	the	the	B-NP	DT	O	26	NMOD	O
T4	B-Protein	B-Protein	698	702	TCRG	TCRG	I-NP	NN	B-DNA	26	NMOD	B-DNA
T14	B-Entity	B-Entity	703	711	enhancer	enhancer	I-NP	NN	I-DNA	23	PMOD	I-DNA
O	O	O	711	712	.	.	O	.	O	13	P	O

O	O	O	713	716	Our	Our	B-NP	PRP$	O	2	NMOD	O
O	O	O	717	724	studies	study	I-NP	NNS	O	3	SUB	O
O	O	O	725	732	provide	provide	B-VP	VBP	O	0	ROOT	O
O	O	O	733	735	an	an	B-NP	DT	O	5	NMOD	O
O	O	O	736	747	explanation	explanation	I-NP	NN	O	3	OBJ	O
O	O	O	748	751	for	for	B-PP	IN	O	5	NMOD	O
O	O	O	752	753	a	a	B-NP	DT	O	9	NMOD	O
O	O	O	754	762	previous	previous	I-NP	JJ	O	9	NMOD	O
O	O	O	763	774	observation	observation	I-NP	NN	O	6	PMOD	O
O	O	O	775	779	that	that	B-NP	IN	O	9	NMOD	O
T5	B-Protein	B-Protein	780	784	TCRG	TCRG	B-NP	NN	B-RNA	12	NMOD	B-RNA
O	O	O	785	789	mRNA	mRNA	I-NP	NN	I-RNA	13	NMOD	I-RNA
O	O	O	790	796	levels	level	I-NP	NNS	O	28	SUB	O
O	O	O	796	797	,	,	O	,	O	28	P	O
O	O	O	798	801	but	but	O	CC	O	28	VMOD	O
O	O	O	802	805	not	not	O	RB	O	15	DEP	O
O	O	O	806	810	mRNA	mRNA	B-NP	NN	O	18	NMOD	O
O	O	O	811	817	levels	level	I-NP	NNS	O	28	SUB	O
O	O	O	818	821	for	for	B-PP	IN	O	18	NMOD	O
O	O	O	822	823	T	T	B-NP	NN	B-protein	23	NMOD	B-protein
O	O	O	824	828	cell	cell	I-NP	NN	I-protein	23	NMOD	I-protein
O	O	O	829	837	receptor	receptor	I-NP	NN	I-protein	23	NMOD	I-protein
O	O	O	838	843	alpha	alpha	B-NP	SYM	I-protein	26	NMOD	I-protein
O	O	O	844	847	and	and	O	CC	I-protein	26	NMOD	I-protein
O	O	O	848	849	-	-	O	HYPH	I-protein	26	NMOD	I-protein
O	O	O	849	853	beta	beta	B-NP	SYM	I-protein	19	PMOD	I-protein
O	O	O	853	854	,	,	O	,	O	26	P	O
O	O	O	855	858	are	be	B-VP	VBP	O	10	SBAR	O
O	O	O	859	868	increased	increase	I-VP	VBN	O	28	VC	O
O	O	O	869	871	by	by	B-PP	IN	O	29	VMOD	O
O	O	O	872	881	ionomycin	ionomycin	B-NP	NN	O	32	NMOD	O
O	O	O	882	891	treatment	treatment	I-NP	NN	O	30	PMOD	O
O	O	O	891	892	.	.	O	.	O	3	P	O
